secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pediatrix Medical Group, Inc. (MD)
CIK:        0000893949
Form:       8-K
Filed at:   2026-07-15T11:00:15+00:00
Accession:  0001193125-26-304033
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pediatrix reaffirms FY 2026 Adjusted EBITDA guidance of $280M-$300M; payor mix stable
--------------------------------------------------------------------------------

- Payor mix for Q2 2026 remained stable and unchanged relative to recent historical trends and internal expectations.
- Company has not experienced unfavorable payor mix shifts reported elsewhere in healthcare sector.
- Reaffirms full year 2026 Adjusted EBITDA outlook in range of $280 million to $300 million.
- No material changes in other net revenue-related trends compared to recent historical periods.
- Earnings conference call scheduled for August 4, 2026 at 9:00 a.m. ET to discuss Q2 results.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/893949/000119312526304033/0001193125-26-304033-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/893949/000119312526304033/md-20260715.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-304033

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer